Scientific Board

Scientific Board

RESEARCH CARRIED OUT BY: FELIPE OYARZÚN AND ANDREW QUEST

Download Universidad de Chile research (Study published in Nanoscale Magazine) 2mg file weight

Felipe Oyarzún

(Pharmaceutical Chemist, PhD in Drug R&D and postdoctoral degree in Therapeutic Materials) is an academic of the Faculty of Chemical and Pharmaceutical Sciences of the University of Chile.

To date, it has 35 ISI publications, 1 non-ISI publication, 3 book chapters, 2 international patents accepted, 1 provisional patent, 6 patent applications, 4 trademarks and has submitted more than 70 papers in national and international conferences.

Most of Dr. Oyarzún's research is related to the design, development and evaluation of new medications. Felipe is a shareholder and director of Matchetune.

Andrew Quest

Senior Academician of the Faculty of Medicine of the University of Chile.

He has a Biochemical training and with doctoral and postdoctoral studies related to cell physiology, highlighting his great experience in the pathophysiology of Cancer.

Dr. Quest has been responsible for more than 25 relevant projects such as: Fondecyt, Fondap, Anillo, among others. He has directed more than 25 doctoral theses and more than 10 postdoctoral students. Dr. Quest has more than 140 ISI publications, is the inventor of 3 patents and has been a guest editor of important journals in the field of Molecular Biology and Cancer. Andrew is a shareholder and director of Matchetune.

What are you looking for?